SUBSCRIBE
SUBSCRIBE

Asia

Drug Development
Biopharma Update on the Novel Coronavirus: August 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
August 13, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
August 11, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 10, 2020.
August 10, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Business
Novavax and SIPL to Develop 1 Billion COVID-19 Vaccine Doses for India, Other Countries
Novavax said the agreement will allow for the development and distribution of NVX‑CoV2373, a recombinant vaccine engineered from the genetic sequence of SARS-CoV-2, in India and in low- and middle-income countries.
August 7, 2020
 · 
2 min read
 · 
Alex Keown
BioCapital
Clinical Catch-Up: August 3-7
It was a moderately busy week for clinical trial news, with some particularly interesting announcements related COVID-19 vaccine trials. Here’s a look.
August 6, 2020
 · 
8 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 7
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.
August 6, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
BioMidwest
Research Roundup: Possible COVID-19 Treatment and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
August 6, 2020
 · 
5 min read
 · 
Mark Terry
Business
AstraZeneca Signs First COVID-19 Vaccine Deal with China’s Shenzhen Kangtai
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products to manufacture AstraZeneca and the University of Oxford’s COVID-19 vaccine in mainland China.
August 6, 2020
 · 
3 min read
 · 
Mark Terry
Genetown
GentiBio Launches with $20 Million Seed Funding from Novartis and Others
GentiBio focuses on engineered regulatory T-cells (EngTregs) to treat autoimmune, alloimmune, autoinflammatory and allergic diseases.
August 5, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
August 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
 · 
2 min read
Press Releases
Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
February 19, 2026
 · 
16 min read
Press Releases
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency
February 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
February 19, 2026
 · 
10 min read
Press Releases
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
February 18, 2026
 · 
6 min read
Press Releases
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases
February 18, 2026
 · 
3 min read
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
 · 
3 min read
Press Releases
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
February 18, 2026
 · 
6 min read
Press Releases
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
February 18, 2026
 · 
8 min read
Press Releases
Adagene to Participate in Two Upcoming Investor Conferences - February 17, 2026
February 17, 2026
 · 
3 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
 · 
5 min read
Press Releases
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
February 17, 2026
 · 
6 min read
Press Releases
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
February 16, 2026
 · 
5 min read
Press Releases
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday
February 16, 2026
 · 
7 min read
Press Releases
CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
February 16, 2026
 · 
4 min read
Press Releases
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
February 13, 2026
 · 
5 min read
Press Releases
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
 · 
5 min read
Press Releases
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
February 13, 2026
 · 
7 min read
Press Releases
World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
February 13, 2026
 · 
5 min read
Press Releases
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
February 13, 2026
 · 
12 min read
Load More